Dragon Pharma Vesilute: Vascular Health Peptide
For athletes, bodybuilders, and fitness enthusiasts, cardiovascular health is the foundation of performance, endurance, and recovery. The vascular system delivers oxygen, nutrients, and hormones to working muscles while removing metabolic waste products. Vesilute is a short, vascular-health peptide (H-Glu-Asp-OH) designed to support cardiovascular function by promoting endothelial regeneration, improving circulation, and reducing inflammation. This Dragon Pharma Vesilute 20mg offering delivers high-purity lyophilized powder in a sterile 2mL vial, providing researchers with a premium compound for advanced cardiovascular, endothelial, and circulatory research.
Vesilute functions as a dipeptide (glutamic acid-aspartic acid) that supports the health and regeneration of the endothelium—the thin layer of cells lining blood vessels. A healthy endothelium is essential for proper vascular function, including the regulation of blood flow, nutrient delivery, and the prevention of inflammation. Research published in the NIH PubMed database demonstrates that peptides supporting endothelial function play a critical role in maintaining vascular integrity, promoting circulation, and reducing vascular inflammation. Vesilute's targeted mechanism offers researchers a tool to study endothelial health, vascular repair, and circulatory optimization.
The relevance of Vesilute to the athletic and bodybuilding community is significant. Intense training places substantial demands on the cardiovascular system, and optimal blood flow is essential for delivering oxygen and nutrients to working muscles while facilitating recovery. Additionally, certain performance-enhancing compounds can impact vascular health and endothelial function. Vesilute offers researchers a tool to study endothelial regeneration, vascular repair, and circulatory support. Its role in reducing vascular inflammation may also have implications for recovery from training-induced stress. The 20mg vial provides a substantial quantity for extended research protocols.
Quality assurance is paramount in peptide research. Each batch of our Vesilute 20 mg inventory undergoes rigorous third-party HPLC-MS testing to verify purity and dosage. Lab test documentation will be available shortly, reflecting Dragon Pharma's commitment to transparency and quality across all products.
For bodybuilders and strength athletes researching cardiovascular health and circulatory optimization, Vesilute offers a unique tool for studying endothelial regeneration and vascular function. Its targeted mechanism supporting the endothelium makes it valuable for research into vascular health, circulation, and recovery. Whether investigating strategies for vascular support, endothelial health optimization, or circulatory enhancement, Dragon Pharma's Vesilute delivers the purity, potency, and reliability required for serious research into cardiovascular and vascular biology.
Note: This product is intended for laboratory research and scientific investigation purposes only. Not for human consumption or veterinary use.
Usage Guidelines
Vesilute is supplied as a sterile lyophilized powder and must be reconstituted with bacteriostatic water prior to research use. For optimal stability, gently swirl the vial after adding the diluent—do not shake vigorously. Standard research protocols involve reconstituting the 20mg peptide with 2-4mL of bacteriostatic water, yielding a concentration of 5-10mg/mL. Typical research dosing ranges from 0.5-2mg per administration, often administered daily or every other day via subcutaneous injection. Due to its role in supporting endothelial health and circulation, long-term dosing protocols are common in research settings. It is recommended to store the reconstituted peptide in a refrigerator (2-8°C) and use within 30 days to maintain peptide integrity.
For researchers investigating comprehensive cardiovascular and vascular health protocols, combining Vesilute with complementary compounds can yield synergistic insights. Consider exploring the following Dragon Pharma products to enhance your research:
- SS-31: A mitochondrial-targeted peptide studied for cellular energy and cardiovascular health.
- BPC 157: A regenerative peptide studied for its effects on blood flow and tissue repair.
- TB 500: A thymosin beta-4 peptide studied for angiogenesis and vascular health.